Innovent Biologics's market cap is currently $17.88B. The company's EPS TTM is $0.07219101; its P/E ratio is 110.18; Innovent Biologics is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.
